M1 muscarinic receptor activation protects neurons from β-amyloid toxicity. A role for Wnt signaling pathway

Amyloid-β-peptide (Aβ) deposits are one of the hallmark features of Alzheimer's disease. Signal transduction alterations are implicate in the neuronal responses to Aβ, which include neurotransmitter systems and pathways involved in the maintenance of the nervous system. In this context, we have...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of disease Vol. 17; no. 2; pp. 337 - 348
Main Authors Farías, Ginny G., Godoy, Juan A., Hernández, Félix, Avila, Jesús, Fisher, Abraham, Inestrosa, Nibaldo C.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2004
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Amyloid-β-peptide (Aβ) deposits are one of the hallmark features of Alzheimer's disease. Signal transduction alterations are implicate in the neuronal responses to Aβ, which include neurotransmitter systems and pathways involved in the maintenance of the nervous system. In this context, we have recently found that Aβ-neurotoxicity triggers a loss of Wnt signaling. We report here that M1-acetylcholine-muscarinic-receptor (mAChR) activation protects neurons from Aβ-toxicity. Concomitant with this effect, a modulation of the Wnt signaling was observed. M1 mAChR activation inhibits glycogen-synthase-kinase-3β (GSK-3β) activity, stabilizes cytoplasmic and nuclear β-catenin, and induces the expression of the Wnt target genes engrailed and cyclin-D1, reverting the switch off of the Wnt pathway caused by Aβ-toxicity. Neurons from mice that overexpress GSK-3β allow us to establish that M1 mAChR stimulation leads to GSK-3β inactivation. We conclude that the cross-talk between the muscarinic signaling and Wnt components underlie the neuroprotective effect of the M1 mAChR activation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0969-9961
1095-953X
DOI:10.1016/j.nbd.2004.07.016